VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-01580
Package ID: USCOURTS-cofc-1_16-vv-01580
Petitioner: James Abdelnour
Filed: 2016-11-29
Decided: 2022-09-27
Vaccine: influenza
Vaccination date: 2014-09-11
Condition: Guillain-Barré syndrome (GBS) or Chronic Immune Demyelination Polyneuropathy (CIDP)
Outcome: compensated
Award amount USD: 153467

AI-assisted case summary:
On November 29, 2016, James Abdelnour filed a petition seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered from Guillain-Barré syndrome (GBS) or Chronic Immune Demyelination Polyneuropathy (CIDP) as a result of an influenza vaccination received on September 11, 2014. The respondent denied that the flu vaccine caused petitioner's condition. However, both parties agreed to settle the case through a joint stipulation filed on June 27, 2022. Special Master Katherine E. Oler reviewed the stipulation and found it reasonable, adopting it as the decision of the court. The stipulation awarded James Abdelnour a lump sum of $145,000.00, payable to him, and an additional $8,467.27 to reimburse a Medicaid lien for services rendered by the Commonwealth of Massachusetts. This award compensates for all damages available under the program. The Special Master directed that judgment be entered based on this stipulation. Petitioner was represented by Jeffrey Pop of Jeffrey S. Pop & Associates, and respondent was represented by Amanda Pascuito of the U.S. Department of Justice.

Theory of causation field:
James Abdelnour alleged that an influenza vaccination received on September 11, 2014, caused him to suffer from Guillain-Barré syndrome (GBS) or Chronic Immune Demyelination Polyneuropathy (CIDP). The respondent denied causation. The parties reached a settlement via joint stipulation, which was adopted by Special Master Katherine E. Oler. The stipulation awarded $145,000.00 as a lump sum to the petitioner and $8,467.27 for reimbursement of a Medicaid lien. The public decision does not detail the specific medical experts, clinical findings, onset, symptoms, treatments, or the precise mechanism of causation relied upon by either party or the Special Master, as the case was resolved by stipulation.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-01580-0
Date issued/filed: 2021-05-10
Pages: 6
Docket text: PUBLIC ORDER/RULING (Originally filed: 3/30/2021) regarding 75 FINDINGS OF FACT REGARDING ONSET. Signed by Special Master Katherine E. Oler. (sl) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-01580-UNJ Document 81 Filed 05/10/21 Page 1 of 6
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-1580V
Filed: March 30, 2021
* * * * * * * * * * * * * * * * * * * * * * * * * *
*
*
JAMES ABDELNOUR,
*
* UNPUBLISHED
Petitioner, *
*
*
v. * Findings of Fact; Onset;
* Influenza (“Flu”) Vaccine; Chronic
SECRETARY OF HEALTH AND * Inflammatory Demyelinating
HUMAN SERVICES, * Polyneuropathy (“CIDP”).
*
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * *
Jeffrey Pop, Jeffrey S. Pop & Associates, Beverly Hills, CA, for Petitioner
Laurie Wiesner, U.S. Department of Justice, Washington, DC, for Respondent
RULING ON ONSET1
Oler, Special Master:
On November 29, 2016, James Abdelnour (“Petitioner”) filed a petition for compensation
under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10, et seq.2 (the
“Vaccine Act” or “Program”). The petition alleges that he suffered from Guillain-Barré syndrome
1 Because this unpublished Ruling contains a reasoned explanation for the action in this case, I intend to
post it on the United States Court of Federal Claims' website, in accordance with the E-Government Act of
2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government
Services). This means the Ruling will be available to anyone with access to the internet. However, the
parties may object to the Ruling’s inclusion of certain kinds of confidential information. Specifically, under
Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information
furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged
or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute
a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Ruling will be
available to the public. Id.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).
1

Case 1:16-vv-01580-UNJ Document 81 Filed 05/10/21 Page 2 of 6
and chronic inflammatory demyelinating polyneuropathy (“CIDP”) as a result of the influenza
vaccine he received on September 11, 2014. Pet. at 1, ECF No. 1.
After carefully considering the medical records, the affidavits, the documentary evidence,
and the witness testimony, I find that Petitioner’s CIDP began around mid-October 2014.
I. Procedural History
In support of his Petition, Petitioner filed medical records and massage therapy records on
December 5, 2016 (Exs. 3-19); which were re-filed on March 1, 2021, August 25, 2020 (Exs. 56-
64) and March 4 and 5, 2021 (Exs. 83-84). Petitioner filed a declaration on December 5, 2016 (Ex.
1) and a supplement affidavit from Soniya Roderiques on February 11, 2021 (Ex. 65).
On June 26, 2017, Respondent filed a Rule 4(c) Report, concluding this case was not
appropriate for compensation under the terms of the Vaccine Act. Respt’s Rep. at 1, ECF No. 16.
On October 24, 2017, Petitioner filed an expert report from Dr. Lawrence Steinman. Ex. 21, ECF
No. 24. Petitioner filed medical literature cited in Dr. Steinman’s report on November 1, 2017.
Exs. 22-45.
This case was re-assigned to my docket on December 6, 2017. ECF No. 31. Respondent
filed an expert report from Dr. Eric Lancaster on February 26, 2018. Ex. A, ECF No. 32. On
September 16, 2019, Petitioner filed a supplemental expert report from Dr. Steinman. Ex. 46, ECF
No. 34.
On November 18, 2019, I held a status conference with the parties to discuss the possibility
of a litigative risk settlement. ECF No. 35. Respondent’s counsel requested 30 days to speak with
his client and 45 days to file a supplement expert report from Dr. Lancaster. See id. at 1. I granted
that request. See id. On December 18, 2019, Respondent filed a status report stating he was not
interested in settlement. Pet’r’s Status Rep. on 12/18/19 at 1, ECF No. 36. On April 20, 2020,
Respondent filed a supplement expert report from Dr. Lancaster and a report from Dr. Yang Zhang.
Ex. DD, ECF No. 39; Ex. M, ECF No. 40.
On July 1, 2020, I held a status conference with the parties to discuss dates for an
entitlement hearing. ECF No. 43. I again encouraged the parties to consider a litigative risk
settlement. See id.
On August 25, 2020, Petitioner file a status report stating he had submitted a settlement
demand to Respondent. ECF No. 47. On August 28, 2020, I scheduled an entitlement hearing for
March 11 and 12, 2021. Scheduling Order dated 8/28/2020. On November 2, 2020, Respondent
filed a status report stating he was not interested in settlement at this time. ECF No. 50.
On March 11 and 12, 2021, I held an entitlement hearing via Zoom. See Minute Entry on
3/12/2021. At the beginning of the hearing, Petitioner’s counsel, Mr. Pop, indicated he believed
the crux of this case revolved around the onset of Petitioner’s CIDP and asked if I would rule on
that issue alone. At the end of the entitlement hearing, I informed the parties that I would conduct
a status conference where I would orally convey my findings with respect to onset.
2

Case 1:16-vv-01580-UNJ Document 81 Filed 05/10/21 Page 3 of 6
On March 19, 2021, I held a status conference and provided oral findings regarding the
issue of onset. See Minute Entry on 3/19/2021. These written findings summarize the findings I
discussed with the parties during this status conference.
II. Legal Standard Regarding Fact Finding
Petitioner bears the burden of establishing her claim by a preponderance of the evidence.
42 U.S.C. § 300aa-13(1)(a). A petitioner must offer evidence that leads the “trier of fact to believe
that the existence of a fact is more probable than its nonexistence before [he or she] may find in
favor of the party who has the burden to persuade the judge of the fact’s existence.” Moberly v.
Sec’y of Health & Hum. Servs., 592 F.3d 1315, 1322 n.2 (Fed. Cir. 2010) (citations omitted).
In order to make a determination concerning factual issues, such as the timing of onset of
petitioner’s alleged injury, the special master should first look to the medical records. “Medical
records, in general, warrant consideration as trustworthy evidence. The records contain
information supplied to or by health professionals to facilitate diagnosis and treatment of medical
conditions. With proper treatment hanging in the balance, accuracy has an extra premium.”
Cucuras v. Sec’y of Health & Hum. Servs., 993 F.2d 1525, 1528 (Fed. Cir. 1993); Lowrie v. Sec’y
of Health & Hum. Servs., No. 03-1585V, 2006 WL 3734216, at *8 (Fed. Cl. Spec. Mstr. Nov. 29,
2006). Medical records created contemporaneously with the events they describe are presumed to
be accurate and complete. Doe/70 v. Sec’y of Health & Hum. Servs., 95 Fed. Cl. 598, 608 (2010).
Contemporaneous medical records generally merit greater evidentiary weight than oral
testimony; this is particularly true where such testimony conflicts with the record evidence.
Cucuras, 993 F.2d at 1528; see also Murphy v. Sec’y of Health & Hum. Servs., 23 Cl. Ct. 726, 733
(1991), aff’d, 968 F.2d 1226 (Fed. Cir. 1992)(citing United States v. United States Gypsum Co.,
333 U.S. 364, 396 (1947) (“It has generally been held that oral testimony which is in conflict with
contemporaneous documents is entitled to little evidentiary weight”)). “Written documentation
recorded by a disinterested person at or soon after the event at issue is generally more reliable than
the recollection of a party to a lawsuit many years later.” Reusser v. Sec’y of Health & Hum. Servs.,
28 Fed. Cl. 516, 523 (1993).
However, there are situations in which compelling oral testimony may be more persuasive
than written records--for instance in cases where records are found to be incomplete or inaccurate.
Campbell, 69 Fed. Cl. at 779 (“like any norm based upon common sense and experience, this rule
should not be treated as an absolute and must yield where the factual predicates for its application
are weak or lacking”); Lowrie, 2005 WL 6117475, at *19 (“Written records which are, themselves,
inconsistent, should be accorded less deference than those which are internally consistent”)
(quoting Murphy, 23 Cl. Ct. at 733).
When witness testimony is used to overcome the presumption of accuracy afforded to
contemporaneous medical records, such testimony must be “consistent, clear, cogent, and
compelling.” Sanchez v. Sec’y of Health & Hum. Servs., No. 11-685V, 2013 WL 1880825 (Fed.
Cl. Spec. Mstr. Apr. 10, 2013) (citing Blutstein v. Sec’y of Health & Hum. Servs., No. 90-2808V,
1998 WL 408611, at *5 (Fed. Cl. Spec. Mstr. June 30, 1998)). In determining the accuracy and
3

Case 1:16-vv-01580-UNJ Document 81 Filed 05/10/21 Page 4 of 6
completeness of medical records, the Court of Federal Claims has suggested four possible
explanations for inconsistencies between contemporaneously created medical records and later
testimony: (1) a person’s failure to recount to the medical professional everything that happened
during the relevant time period; (2) the medical professional’s failure to document everything
reported to her or him; (3) a person’s faulty recollection of the events when presenting testimony;
or (4) a person’s purposeful recounting of symptoms that did not exist. La Londe v. Sec’y of Health
& Hum. Servs., 110 Fed. Cl. 184, 203-04 (2013), aff’d, 746 F.3d 1334 (Fed. Cir. 2014). A special
master making a determination whether to afford greater weight to contemporaneous medical
records or other evidence, such as testimony at a hearing must have evidence suggesting the
decision was a rational determination. Burns by Burns v. Sec’y of Health & Hum. Servs., 3 F.3d
415, 417 (Fed. Cir. 1993).
III. Findings of Fact
The issue of onset in this case is complicated by Petitioner’s pre-existing diabetic
neuropathy. Parsing the distinction between these two diseases is not entirely straightforward.
Petitioner’s expert, Dr. Steinman, testified that Petitioner most likely began to experience
symptoms of CIDP in the mid-October 2014 timeframe. Respondent’s expert, Dr. Lancaster,
testified that Petitioner’s symptoms began around late November 2014. Both sides find support for
their positions in the medical records. In other words, some of the medical records contradict other
records filed in this case. Because of that, this issue is a close one. Ultimately, I find that the
preponderance of the evidence favors an onset of CIDP in the mid-October 2014 timeframe.
On October 16, 2014, Petitioner visited his cardiologist, Dr. Milan. During this
appointment, Petitioner reported fatigue, difficulty walking, numbness, and weakness. Ex. 4 at
106. This visit represented the first time that weakness appeared in Petitioner’s medical records
after his flu vaccine. Dr. Lancaster has opined that the notation of weakness in the medical records
signifies the beginning of Petitioner’s disease. “If the sensory symptoms [in June] were actually due
to diabetic neuropathy, then we should date his CIDP to the onset of weakness.” First Lancaster Rep.
at 4.
This particular appointment on October 16, 2014 can be compared with Petitioner’s
previous visit with Dr. Milan on September 25, 2014. When describing the September visit in his
expert report, Dr. Lancaster stated, “A review of symptoms was negative for some symptoms of
neuropathy such as numbness and weakness.” First Lancaster Rep. at 2; see also Ex. 4 at 108-11.
These two records (from the same provider) indicate that in September, Petitioner was not
experiencing numbness or weakness, but demonstrate that he was experiencing these symptoms in
mid-October.
During the entitlement hearing, Dr. Lancaster testified that the term “weakness” from this
October 16, 2014 record should be discounted because the objective examination did not confirm
Petitioner’s weakness. While this evidence would be stronger if it had been corroborated with
physical exam findings, I find that this notation still supports an onset of weakness in the mid-
October timeframe, and thus an onset of CIDP.
4

Case 1:16-vv-01580-UNJ Document 81 Filed 05/10/21 Page 5 of 6
On October 18, 2014, Petitioner did not attend a wedding due to his condition. Petitioner’s
and Ms. Roderiques’ testimony were credible and consistent with the medical records filed in this
case. Petitioner’s inability to attend this event supports the proposition that his disease course was
worsening.
The November 5, 2014 records from Caregiver Homes note that Petitioner had to use a
walker or crutch while walking outside. Ex. 58 at 62. This record also suggests the further
progression of Petitioner’s disease and is consistent with onset of CIDP in the mid-October
timeframe (as opposed to the late November timeframe suggested by Dr. Lancaster).
On November 19, 2014, Petitioner saw Dr. Vallone and reported symptoms of difficulty
walking, painful legs with exercise, numbness, and weakness. Ex. 7 at 180; Ex. 8 at 1-5.
During late November and early December 2014, Petitioner fell several times. This was
documented in Ms. Roderiques’ calendar and in a phone call to New Bedford Community Health
Center. Ex. 66 at 17; Ex. 83 at 12.
On January 10, 2015, Petitioner was admitted to the Brigham & Women’s Hospital
Emergency Department with a chief complaint of weakness. Ex. 10 at 97-98. Petitioner noted that
“in mid-October [] his legs were getting more easily exhausted again and he didn’t have the same
energy. Over the last 4-6 weeks, the weakness has progressed more quickly.” Id. at 97. This
notation indicates that the terms “easily exhausted” and “weakness” are synonymous. Based on
this January 10, 2015 record, Petitioner’s weakness began in mid-October 2014.
In an attending note dated 1/12/2015 from Sarah Frasure, M.D. Attending/Fellow, the
records document that Petitioner’s symptoms had been going on for a few months but had recently
increased to the point where he could no longer get up the stairs of his house without his wife
pushing him from behind. Ex. 10 at 101. The notation of “a few months” is consistent with an
onset of symptoms in mid-October 2014 coupled with a subsequent worsening.
On September 10, 2018, Petitioner had his first appointment with Dr. Christopher Doughty,
a neurologist. Dr. Doughty noted in the HPI section of that record that Petitioner’s CIDP
“symptoms progressed over a six-week period after the flu shot leading to an admission at BWH
in January 2015.” Ex. 57 at 185. Six weeks after Petitioner’s September 11, 2014 vaccination is
October 23, 2014. This entry also supports an onset of Petitioner’s CIDP in the mid-October 2014
timeframe.
There are several medical records which suggest a later onset of CIDP. See e.g. Ex. 10 at
183, (a January 12, 2015 Brigham and Women’s Hospital Occupational Therapy evaluation noting
that prior to November 2014, Petitioner had “returned to being independent with basic ADL’s and
functional mobility” and that since November, “he has progressively required more assistance
w/mobility and ADL's.”); Ex. 10 at 9 (noting that Petitioner’s symptoms began approximately six
weeks before his January 10, 2015 hospital admission); Ex. 56 at 10 (noting that Petitioner’s CIDP
started around November 2014).
5

Case 1:16-vv-01580-UNJ Document 81 Filed 05/10/21 Page 6 of 6
I have considered these records which suggest an onset in November 2014 in arriving at
my determination. As delineated above, the medical records in this case are not entirely consistent
with one another. However, I find that the preponderant weight of the records suggests that the
onset of Petitioner’s CIDP began in mid-October 2014. The affidavits submitted by and on behalf
of Petitioner, the testimony, and the other documentary evidence also support Petitioner’s case,
and work in concert with the medical records to help Petitioner meet his burden.
The following is therefore ORDERED:
By Monday, April 26, 2021, Respondent shall file a status report indicating how he would
like to proceed.
IT IS SO ORDERED.
s/ Katherine E. Oler
Katherine E. Oler
Special Master
6

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_16-vv-01580-1
Date issued/filed: 2022-09-27
Pages: 8
Docket text: PUBLIC DECISION (Originally filed: 6/27/2022) regarding 97 DECISION of Special Master - Stipulation. Signed by Special Master Katherine E. Oler. (sl) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 1 of 8
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-1580V
(not to be published)
* * * * * * * * * * * * * * * * * * * * * * * * * *
*
*
JAMES ABDELNOUR,
*
* Filed: June 27, 2022
Petitioner, *
*
*
v. * Decision by Stipulation; Damages;
* Influenza (“Flu”) Vaccine; Guillain-Barré
SECRETARY OF HEALTH AND * syndrome (“GBS”); Chronic Immune
HUMAN SERVICES, * Demyelination Polyneuropathy (“CIDP”).
*
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * *
Jeffrey Pop, Jeffrey S. Pop & Associates, Beverly Hills, CA, for Petitioner
Amanda Pascuito, U.S. Department of Justice, Washington, DC, for Respondent
DECISION ON JOINT STIPULATION1
On November 29, 2016, James Abdelnour (“Petitioner”) filed a petition, seeking
compensation under the National Vaccine Injury Compensation Program (“the Vaccine
Program”).2 Pet., ECF No. 1. Petitioner alleges he suffered from Guillain-Barré syndrome (“GBS”)
or Chronic Immune Demyelination Polyneuropathy (“CIDP”) as a result of the influenza (“flu”)
vaccination he received on September 11, 2014. See Stipulation ¶ 2, 4, dated June 27, 2022 (ECF
No. 96); see also Pet.
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the Decision will be available to anyone with access to the internet. As
provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of
certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen
days within which to request redaction “of any information furnished by that party: (1) that is a trade secret
or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.”
Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter
“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
pertinent subparagraph of 42 U.S.C. § 300aa.

Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 2 of 8
Respondent denies “that the flu vaccine caused petitioner to suffer from GBS, CIDP, or
any other injury or his current condition.” See Stipulation ¶ 6. Nonetheless, both parties, while
maintaining their above-stated positions, agreed in a stipulation filed June 27, 2022 that the issues
before them can be settled and that a decision should be entered awarding Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
therein.
The stipulation awards:
1. A lump sum of $145,000.00 in the form of a check payable to petitioner; and
2. A lump sum of $8,467.27, representing reimbursement of a Medicaid lien for services
rendered to petitioner by the Commonwealth of Massachusetts, in the form of a check
payable jointly to petitioner and the Commonwealth of Massachusetts – Casualty Recovery
Unit, to be sent to:
Commonwealth of MA
Casualty Recovery
P.O. Box 417811
Boston, MA 02241-7811
Attention: Linda McGahey
Case #: CRG6940549
Petitioner agrees to endorse this check to Commonwealth of Massachusetts – Casualty
Recovery Unit.
Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a).
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
the Court is directed to enter judgment herewith.3
IT IS SO ORDERED.
s/ Katherine E. Oler
Katherine E. Oler
Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
renouncing their right to seek review.

Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 3 of 8

Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 4 of 8

Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 5 of 8

Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 6 of 8

Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 7 of 8

Case 1:16-vv-01580-UNJ Document 104 Filed 09/27/22 Page 8 of 8